NCT05184738View on ClinicalTrials.gov

Nutritional Supplements in Patients with Anorexia Nervosa

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

March 12, 2022

Study Completion Date

May 22, 2022

Conditions
Anorexia Nervosa
Interventions
OTHER

Experimental Treatment, Oligomeric nutritional formula

Intervention group will receive a oligomeric nutritional formula (Bi1 peptidic Adventia Pharma, Spain).

OTHER

Control Treatment

Standard nutritional formula (isocaloric and isoprotein compared to the experimental treatment).

Trial Locations (1)

29009

Hospital Regional Universitario de Málaga, Málaga

All Listed Sponsors
lead

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

OTHER

NCT05184738 - Nutritional Supplements in Patients with Anorexia Nervosa | Biotech Hunter | Biotech Hunter